Prospective molecular monitoring of minimal residual disease after non-myeloablative allografting in newly diagnosed multiple myeloma. 2016

M Ladetto, and S Ferrero, and D Drandi, and M Festuccia, and F Patriarca, and N Mordini, and S Cena, and R Benedetto, and G Guarona, and F Ferrando, and L Brunello, and P Ghione, and V Boccasavia, and R Fanin, and P Omedè, and L Giaccone, and A Palumbo, and R Passera, and M Boccadoro, and B Bruno
Division of Hematology, A.O.U. Città della Salute e della Scienza di Torino, University of Torino, Torino, Italy.

UI MeSH Term Description Entries
D009101 Multiple Myeloma A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY. Myeloma, Plasma-Cell,Kahler Disease,Myeloma, Multiple,Myeloma-Multiple,Myelomatosis,Plasma Cell Myeloma,Cell Myeloma, Plasma,Cell Myelomas, Plasma,Disease, Kahler,Multiple Myelomas,Myeloma Multiple,Myeloma, Plasma Cell,Myeloma-Multiples,Myelomas, Multiple,Myelomas, Plasma Cell,Myelomas, Plasma-Cell,Myelomatoses,Plasma Cell Myelomas,Plasma-Cell Myeloma,Plasma-Cell Myelomas
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000971 Antineoplastic Combined Chemotherapy Protocols The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form. Anticancer Drug Combinations,Antineoplastic Agents, Combined,Antineoplastic Chemotherapy Protocols,Antineoplastic Drug Combinations,Cancer Chemotherapy Protocols,Chemotherapy Protocols, Antineoplastic,Drug Combinations, Antineoplastic,Antineoplastic Combined Chemotherapy Regimens,Combined Antineoplastic Agents,Agent, Combined Antineoplastic,Agents, Combined Antineoplastic,Anticancer Drug Combination,Antineoplastic Agent, Combined,Antineoplastic Chemotherapy Protocol,Antineoplastic Drug Combination,Cancer Chemotherapy Protocol,Chemotherapy Protocol, Antineoplastic,Chemotherapy Protocol, Cancer,Chemotherapy Protocols, Cancer,Combinations, Antineoplastic Drug,Combined Antineoplastic Agent,Drug Combination, Anticancer,Drug Combination, Antineoplastic,Drug Combinations, Anticancer,Protocol, Antineoplastic Chemotherapy,Protocol, Cancer Chemotherapy,Protocols, Antineoplastic Chemotherapy,Protocols, Cancer Chemotherapy
D014184 Transplantation, Homologous Transplantation between individuals of the same species. Usually refers to genetically disparate individuals in contradistinction to isogeneic transplantation for genetically identical individuals. Transplantation, Allogeneic,Allogeneic Grafting,Allogeneic Transplantation,Allografting,Homografting,Homologous Transplantation,Grafting, Allogeneic
D060888 Real-Time Polymerase Chain Reaction Methods used for detecting the amplified DNA products from the polymerase chain reaction as they accumulate instead of at the end of the reaction. Kinetic Polymerase Chain Reaction,Quantitative Real-Time PCR,Quantitative Real-Time Polymerase Chain Reaction,Real-Time PCR,PCR, Quantitative Real-Time,PCR, Real-Time,PCRs, Quantitative Real-Time,PCRs, Real-Time,Quantitative Real Time PCR,Quantitative Real Time Polymerase Chain Reaction,Quantitative Real-Time PCRs,Real Time PCR,Real Time Polymerase Chain Reaction,Real-Time PCR, Quantitative,Real-Time PCRs,Real-Time PCRs, Quantitative
D018365 Neoplasm, Residual Remnant of a tumor or cancer after primary, potentially curative therapy. Minimal Residual Disease,Residual Cancer,Residual Tumor,Minimal Disease, Residual,Residual Disease, Minimal,Residual Neoplasm,Residual Tumour,Cancer, Residual,Minimal Residual Diseases,Residual Cancers,Residual Minimal Disease,Residual Minimal Diseases,Residual Neoplasms,Residual Tumors,Residual Tumours,Tumour, Residual
D018380 Hematopoietic Stem Cell Transplantation Transfer of HEMATOPOIETIC STEM CELLS from BONE MARROW or BLOOD between individuals within the same species (TRANSPLANTATION, HOMOLOGOUS) or transfer within the same individual (TRANSPLANTATION, AUTOLOGOUS). Hematopoietic stem cell transplantation has been used as an alternative to BONE MARROW TRANSPLANTATION in the treatment of a variety of neoplasms. Stem Cell Transplantation, Hematopoietic,Transplantation, Hematopoietic Stem Cell
D019172 Transplantation Conditioning Preparative treatment of transplant recipient with various conditioning regimens including radiation, immune sera, chemotherapy, and/or immunosuppressive agents, prior to transplantation. Transplantation conditioning is very common before bone marrow transplantation. Conditioning, Transplantation,Conditionings, Transplantation,Transplantation Conditionings

Related Publications

M Ladetto, and S Ferrero, and D Drandi, and M Festuccia, and F Patriarca, and N Mordini, and S Cena, and R Benedetto, and G Guarona, and F Ferrando, and L Brunello, and P Ghione, and V Boccasavia, and R Fanin, and P Omedè, and L Giaccone, and A Palumbo, and R Passera, and M Boccadoro, and B Bruno
March 2023, American journal of hematology,
M Ladetto, and S Ferrero, and D Drandi, and M Festuccia, and F Patriarca, and N Mordini, and S Cena, and R Benedetto, and G Guarona, and F Ferrando, and L Brunello, and P Ghione, and V Boccasavia, and R Fanin, and P Omedè, and L Giaccone, and A Palumbo, and R Passera, and M Boccadoro, and B Bruno
August 2005, Leukemia research,
M Ladetto, and S Ferrero, and D Drandi, and M Festuccia, and F Patriarca, and N Mordini, and S Cena, and R Benedetto, and G Guarona, and F Ferrando, and L Brunello, and P Ghione, and V Boccasavia, and R Fanin, and P Omedè, and L Giaccone, and A Palumbo, and R Passera, and M Boccadoro, and B Bruno
March 2002, Best practice & research. Clinical haematology,
M Ladetto, and S Ferrero, and D Drandi, and M Festuccia, and F Patriarca, and N Mordini, and S Cena, and R Benedetto, and G Guarona, and F Ferrando, and L Brunello, and P Ghione, and V Boccasavia, and R Fanin, and P Omedè, and L Giaccone, and A Palumbo, and R Passera, and M Boccadoro, and B Bruno
February 2004, Hematology (Amsterdam, Netherlands),
M Ladetto, and S Ferrero, and D Drandi, and M Festuccia, and F Patriarca, and N Mordini, and S Cena, and R Benedetto, and G Guarona, and F Ferrando, and L Brunello, and P Ghione, and V Boccasavia, and R Fanin, and P Omedè, and L Giaccone, and A Palumbo, and R Passera, and M Boccadoro, and B Bruno
July 2019, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi,
M Ladetto, and S Ferrero, and D Drandi, and M Festuccia, and F Patriarca, and N Mordini, and S Cena, and R Benedetto, and G Guarona, and F Ferrando, and L Brunello, and P Ghione, and V Boccasavia, and R Fanin, and P Omedè, and L Giaccone, and A Palumbo, and R Passera, and M Boccadoro, and B Bruno
February 2024, Discover. Oncology,
M Ladetto, and S Ferrero, and D Drandi, and M Festuccia, and F Patriarca, and N Mordini, and S Cena, and R Benedetto, and G Guarona, and F Ferrando, and L Brunello, and P Ghione, and V Boccasavia, and R Fanin, and P Omedè, and L Giaccone, and A Palumbo, and R Passera, and M Boccadoro, and B Bruno
November 2023, Critical reviews in clinical laboratory sciences,
M Ladetto, and S Ferrero, and D Drandi, and M Festuccia, and F Patriarca, and N Mordini, and S Cena, and R Benedetto, and G Guarona, and F Ferrando, and L Brunello, and P Ghione, and V Boccasavia, and R Fanin, and P Omedè, and L Giaccone, and A Palumbo, and R Passera, and M Boccadoro, and B Bruno
April 2018, British journal of haematology,
M Ladetto, and S Ferrero, and D Drandi, and M Festuccia, and F Patriarca, and N Mordini, and S Cena, and R Benedetto, and G Guarona, and F Ferrando, and L Brunello, and P Ghione, and V Boccasavia, and R Fanin, and P Omedè, and L Giaccone, and A Palumbo, and R Passera, and M Boccadoro, and B Bruno
August 2022, British journal of haematology,
M Ladetto, and S Ferrero, and D Drandi, and M Festuccia, and F Patriarca, and N Mordini, and S Cena, and R Benedetto, and G Guarona, and F Ferrando, and L Brunello, and P Ghione, and V Boccasavia, and R Fanin, and P Omedè, and L Giaccone, and A Palumbo, and R Passera, and M Boccadoro, and B Bruno
January 2016, Cancer treatment and research,
Copied contents to your clipboard!